Document is current
Any future updates will be listed below
-
Authors
Huuhtanen, Jani https://orcid.org/0000-0003-2750-4033
Adnan-Awad, Shady https://orcid.org/0000-0001-6205-7799
Theodoropoulos, Jason
Forstén, Sofia
Warfvinge, Rebecca
Dufva, Olli https://orcid.org/0000-0002-8084-0282
Bouhlal, Jonas https://orcid.org/0000-0002-7920-3390
Dhapola, Parashar
Duàn, Hanna https://orcid.org/0000-0001-8318-130X
Laajala, Essi
Kasanen, Tiina
Klievink, Jay
Ilander, Mette
Jaatinen, Taina
Olsson-Strömberg, Ulla
Hjorth-Hansen, Henrik
Burchert, Andreas
Karlsson, Göran
Kreutzman, Anna
Lähdesmäki, Harri
Mustjoki, Satu https://orcid.org/0000-0002-0816-8241
- License Information
-
More Information
Article History
Received: 31 March 2023
Revised: 19 September 2023
Accepted: 17 October 2023
First Online: 2 November 2023
Competing interests
: P.D. is currently employed by Nygen Analytics AB. M.I. is currently employed by Bristol Myers Squibb. U.O.S. has received honoraria from Incyte. H.H.H. has received honoraria from Novartis, Bristol Myers Squibb, and Incyte. A.B. has received honoraria from Novartis and MSD. G.K. is currently employed by Nygen Analytics AB. A.K. is currently employed by Bristol Myers Squibb. S.M. has received honoraria from Bristol Myers Squibb and DrenBio and research funding from BMS, Novartis, and Pfizer. All other authors declare no conflicts of interests.
